Logo Annals of Transplantation Logo Annals of Transplantation Logo Annals of Transplantation

08 August 2014 : Original article  

Thiazolidinedione Therapy Versus Lifestyle Recommendation in the Treatment of Post-Liver Transplant Graft Steatosis

Fredrik ÅbergABCDEF, Virve KoljonenABCDEF, Katriina NikkiläABDEF, Sonja BoydBCDE, Johanna ArolaABDE, Helena IsoniemiADE

DOI: 10.12659/AOT.890664

Ann Transplant 2014; 19:389-396

Abstract

BACKGROUND: Few studies have investigated intervention therapy to reduce steatosis in the liver allograft post-transplantation.

MATERIAL AND METHODS: We compared the use of thiazolidinedione (TZD) therapy (rosiglitazone or pioglitazone) with intensified lifestyle recommendation retrospectively in 22 liver transplant patients with ³10% macrovesicular steatosis on biopsies obtained ≥9 months post-transplant.

RESULTS: The 10 patients receiving TZD therapy and 12 receiving intensified lifestyle recommendation were comparable with respect to age, sex, disease etiology, immunosuppression regimen, and diabetes, but patients receiving TZD therapy were less overweight at start of treatment. From baseline to last biopsy, patients subject to lifestyle recommendation (mean follow-up 14 months) lost an average of 3.5 kg body weight, whereas TZD patients (mean follow-up 9 months) gained an average of 4.1 kg. Hepatic macrovesicular steatosis decreased from 63% to 31% among TZD-treated patients (p=0.005), and from 47% to 33% among those subject to lifestyle recommendation (p=0.17). Absolute and percentage change in body weight correlated with the decreased steatosis in the lifestyle group (rho=0.84 and rho=0.87, respectively, p=0.001–0.002), but not in the TZD group (rho=–0.04, p=0.92). Five patients in the TZD group stopped the medication after an average 14 months of therapy.

CONCLUSIONS: Liver graft steatosis can be reduced through weight loss or TZD treatment, but considering the risks and benefits, we advocate lifestyle recommendation as the first-line intervention.

Keywords: Diet, Reducing, Fatty Liver, Life Style, Liver Transplantation, Thiazolidinediones

0 Comments

SARS-CoV-2/COVID-19

29 November 2022 : Editorial  

Editorial: The World Health Organization (WHO) Fungal Priority Pathogens List in Response to Emerging Funga...

Med Sci Monit In Press; DOI: 10.12659/MSM.939088  

15 November 2022 : Original article  

Changes in Physical Activity Due to Fear of COVID-19 and Its Impact on Depression Among Post-Liver Transpla...

Ann Transplant In Press; DOI: 10.12659/AOT.938239  

12 April 2022 : Letter/Correspondence  

Pancreas Allograft Thrombosis as a Post-COVID-19 Complication in a Diabetic Patient After Pancreas Transpla...

Ann Transplant 2022; 27:e935863

In Press

28 Nov 2022 : Original article  

Hepatic Ischemia/Reperfusion Injury After Liver Transplantation Is Not Associated with Early Impairment of ...

Ann Transplant In Press; DOI: 10.12659/AOT.938105  

28 Nov 2022 : Original article  

Modification of Venous Outflow to Avoid Thrombotic Graft Failure in Pancreas Transplantation

Ann Transplant In Press; DOI: 10.12659/AOT.937514  

15 Nov 2022 : Original article  

Changes in Physical Activity Due to Fear of COVID-19 and Its Impact on Depression Among Post-Liver Transpla...

Ann Transplant In Press; DOI: 10.12659/AOT.938239  

14 Nov 2022 : Original article  

Pure Laparoscopic Versus Open Right Hepatectomy in Living Liver Donors: Graft Weight Discrepancy

Ann Transplant In Press; DOI: 10.12659/AOT.938274  

Most Viewed Current Articles

26 Jan 2022 : Review article  

Recurrence of Hepatocellular Carcinoma After Liver Transplantation: Risk Factors and Predictive Models

DOI :10.12659/AOT.934924

Ann Transplant 2022; 27:e934924

24 Jul 2020 : Review article  

Kidney Transplantation in the Times of COVID-19 – A Literature Review

DOI :10.12659/AOT.925755

Ann Transplant 2020; 25:e925755

29 Dec 2021 : Original article  

Efficacy and Safety of Tacrolimus-Based Maintenance Regimens in De Novo Kidney Transplant Recipients: A Sys...

DOI :10.12659/AOT.933588

Ann Transplant 2021; 26:e933588

24 Aug 2021 : Review article  

Normothermic Machine Perfusion (NMP) of the Liver – Current Status and Future Perspectives

DOI :10.12659/AOT.931664

Ann Transplant 2021; 26:e931664

Your Privacy

We use cookies to ensure the functionality of our website, to personalize content and advertising, to provide social media features, and to analyze our traffic. If you allow us to do so, we also inform our social media, advertising and analysis partners about your use of our website, You can decise for yourself which categories you you want to deny or allow. Please note that based on your settings not all functionalities of the site are available. View our privacy policy.

Annals of Transplantation eISSN: 2329-0358
Annals of Transplantation eISSN: 2329-0358